Anani Badje, M., Raoul Moh, P., Delphine Gabillard, M., Calixte Guéhi, P., Mathieu Kabran, P., Jean-Baptiste Ntakpé, M., . . . Xavier Anglaret. (2017). Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: Long-term follow-up of the Temprano ANRS 12136 trial. Elsevier.
Chicago Style (17th ed.) CitationAnani Badje, MPH, et al. Effect of Isoniazid Preventive Therapy on Risk of Death in West African, HIV-infected Adults with High CD4 Cell Counts: Long-term Follow-up of the Temprano ANRS 12136 Trial. Elsevier, 2017.
MLA (9th ed.) CitationAnani Badje, MPH, et al. Effect of Isoniazid Preventive Therapy on Risk of Death in West African, HIV-infected Adults with High CD4 Cell Counts: Long-term Follow-up of the Temprano ANRS 12136 Trial. Elsevier, 2017.